AI assistant
Seeka Limited — Director's Dealing 2019
Oct 16, 2019
66268_rns_2019-10-16_2730fcab-cdc9-44cd-b282-e9850620861f.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [98 x 14] intentionally omitted <==
==> picture [98 x 13] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | Seeka Limited | |
| Date this disclosure made: | 16-Oct-19 | |
| Date of last disclosure: | 12-Apr-19 |
| Director or senior managergiving disclosure | ||
|---|---|---|
| Full name(s): | Fred Allan Hutchings | |
| Name of listed issuer: | Seeka Limited | |
| Name of related body corporate (if applicable): | NA | |
| Position held in listed issuer: | Director | |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
| Class of affected quoted financial products: | OrdinaryShares | |
|---|---|---|
| 1) F Hutchings has the power to exercise the right to vote | ||
| attached to 20% or more of the voting rights of Walker | ||
| Nominees Limited, resulting in F Hutchings having a relevant | ||
| interest in the Ordinary Shares of Seeka Limited held by | ||
| Walker Nominees Limited. | ||
| 2) Seeka Share Trustee Limited holds Ordinary Shares in | ||
| Seeka Limited for and on behalf of Amwell Holdings Limited. | ||
| Nature of the affected relevant interest(s): | F Hutchings is a director of Amwell Holdings Limited. FHutchings is the registered holder of 26.24% of the shares in | |
| Amwell Holdings Limited in his personal capacity and a | ||
| registered holder of 58% of the shares in Amwell Holdings | ||
| Limited jointly with others. As such F Hutchings has the | ||
| power to control the exercise of 20% or more of the voting | ||
| rights of Amwell Holdings Limited, resulting in F Hutchings | ||
| having a relevant interest in the Ordinary Shares of Seeka | ||
| Limited held by Seeka Share Trustee Limited for and on | ||
| behalf of Amwell Holdings Limited. | ||
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 1) 41,450 Ordinary Shares2)2,463 OrdinaryShares | |
| Number held in class after acquisition or disposal: | 1) 42,421 Ordinary Shares2)2,463 OrdinaryShares | |
| Current registered holder(s): | 1) NA2)NA | |
| 1) Walker Nominees Limited | ||
| Registered holder(s) once transfers are registered: | 2) Seeka Share Trustee Limited for and on behalf of Amwell | |
| Holdings Limited. |
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
| Type of affected derivative: | NA | |
|---|---|---|
| Class of underlyingfinancialproducts: | NA | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial | ||
| products(if any): | NA | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | NA | |
| Maturitydate of the derivative(if any): | NA | |
| Expirydate of the derivative(if any): | NA | |
| Theprice specified in the terms of the derivative(if any): | NA | |
| Any other details needed to understand how the amount of the consideration payable | ||
| under the derivative or the value of the derivative is affected by the value of the underlying | ||
| financial products: | NA | |
| _For that derivative,- _ | ||
| Parties to the derivative: | NA | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant | ||
| interest in the derivative: | NA |
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
1
Details of transactions requiring disclosure-
Date of transaction:
Nature of transaction: Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:
Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):
Transaction 9 October 2019 Allotment pursuant to Seeka Limited's Dividend Reinvestment Plan. NA $4,628.8541 (971 Ordinary Shares at $4.7671 each) 971 Ordinary Shares No NA NA
Summary of other relevant interests after acquisition or disposal:
| NA | ||
|---|---|---|
| NA | ||
| NA | ||
| NA | ||
| NA | ||
| The notional value of the derivative (if any) or the notional amount of underlying financialproducts (if any): | NA | |
| A statement as to whether the derivative is cash settled or physically settled: | NA | |
| Maturity date of the derivative (if any): | NA | |
| Expiry date of the derivative (if any): | NA | |
| The price's specified terms (if any): | NA | |
| Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: | NA | |
| For that derivative relevant interest,- | NA | |
| Parties to the derivative: | NA | |
| If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative: | NA |
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature: Name and title of authorised person:
F A Hutchings 16-Oct-19 S MCKinstry 16-Oct-19 S McKinstry - CFO
Notes
Use this form to disclose all the acquisitions and disposals by a director or senior manager of a listed issuer, or of a related body corporate, or in specified derivatives. The disclosure must be made within—
(a) 20 working days after the first acquisition or disposal disclosed in this notice if the acquisitions or disposals are of a kind referred to in section 297(2)(a) of the Financial Markets Conduct Act 2013; or
(b) in any other case, 5 trading days after the first acquisition or disposal disclosed in this notice.